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The hypertrypsinogenemic one-CFTR mutation screened neonates: 
who are they? 
A. Munck 
for French Association for Neonatal Screening Paris, France 
French CFNN screening (two steps IRT DNA)  involved 1 143 248 neonates (NN) 
in 2CO2 2003. A im:  to evaluate the 1 CFTR mutation cobort according to their 
CFhilon CF status. Populat ion:  7782 NN were over the IRT D3 cut off level mild 
7604 had a CFI'R genotyping analysis (Elucigen kit CF 20). Have been referred to 
a CF centre for a sweat test (ST) CI? meq/l, 625 NN with 1 CF IR  mutation (death 
n 9, lost of sight n 17). Results:  Gr I (n 65) as having CF a) ST>60 (n 52), b) 
borderline 30<ST<60 (n~)  with detection of the second mutation, c) ST<30 (n 3) 
with a mutation known to give normal ST plus cl inical CF symptoms or a twin 
brother with an abnormal ST/second mutation. The one mutation CF babies were 
26% of all the CF screened NN, 50% were symptomatic. IRT D3 mean value was 
lower in the 1 CF vs the 2 CF screened babies (127 + 64 vs 153+ 60 p 0.C(K)3); 
IRTD3 was > 1CObtg/l in 60% of the 1 CF vs 83% of the 2 CF NN (Z2p<0.002). 
The incidence of CF among the 1 CFTR mutation is 1/10 but varies f roml/3 for 
IRT D3>leOpg/ l  to 1/20 for IRT D3<leObtg/l. Gr II (n 542): 1) 476 carriers with 
ST<30 whose parents wi l l  receive a genetic counsell ing 2) 52 babies with 
borderline ST. Gr I l l  (n 18) : babies wait ing for a ST. Discussion: a definite 
conclusion on CF status might be difficult to formulate by the CF physician for up 
to 8% (Gr II) of the 1 CFTR mutation babies outl ining the need of an tmiform 
prceedure over the country. Condns ion:  1 CFTR mutation screened NN is an 
heterogeneous population. Borderl ine quantitative ST (30<ST<60) require a 
national prceedure such as an extensive CF IR  genotyping a ST fol low up until a 
definite diaguosis is done and rational explanations to the parents. We outline the 
practical diff iculties of CF NN screening. The authors thank the regional 
associations mild the paediatric CF centres for their contribution. 
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Aim. In order to perform prenatal diaguosis of CF avoiding the r isk of miscarriage, 
we  have developed the ISET (Isolation by Size of Epithel ial  Tumor/Trophoblaslic 
cells) CF assay. Methods include the fol lowing steps: 1) enrichment of circulating 
tropboblastic cells by ISET, identification of epithelial cells by KL1 labelling, single 
cell laser based microdissection of circulating epithelial ce ls, STR (sbott tandem 
repeat) genotyping of laser microdissected single cells with informative primers 
previously tested on PBL (peripheral blood leukceytes)derived paternal mild 
maternal DNA,  detection of CF specific mutations in the single cell DNA proved to 
be fetal by STR genotyping. We blindly tested 12 preguant women whose babies 
were at 1/4 r isk of CF. Ten women were from couples of F508del carriers (direct 
diaguosis) and 2 from caTriers of tmkailown mutations (inldirect diaguosis). In order 
to perform indirect diaguosis, we  used informative STR primers on the cbromosome 
7 (STR markers l inked to the CF gene) and the DNA of an affected chi ld from the 
same family (index case) as reference. Results By analysing 2 or more fetal cells 
per sample, isolated from 2 ml  of blood, we found that 1 fetus was affected by CF, 
7 fetuses were CF carriers and 4 were completely healthy. These results, obtained 
with a completely blind pr ot c¢ol, were consistent with those derived by file invasive 
approach. Conclusions A rel iable and safe prenatal assay for CF is now available to 
be tested by other laboratories, potentially allowing, in the future, a large scale 
screening for CF in preguant women. 
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Follow-up of 17 atypical CF diagnosed by neonatal screening in 
Brittany (France) 
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Quite often atypical CF are diagnosed by neonatal screening and we don't really 
know their evolution, because it's a new problem and it is too soon to assess the 
long t ime effects. 
A ims and  methods Describe the outcome of atypical CF diagnosed at birth from 
the begimiling of our systematic neonatal screening with a regular multidisciplinary 
follow up. 
Results Between 1999 and 2CO3, we  found 17 atypical CF (8,9 % of 190 diaguosed 
CF). 
One child had 2 mild mutations (3849+10kbC >T/3272 26A >G) ; init ial sweat 
chloride (SC) value was 37 raM/L, 66 at 7 months ; the child is normal with 18 
months follow up. 
Sixteen are compound heterozygous classic mutation/mild mutation : 
9 R l l7H (IVSS,7T) ; four with SC < 30, the others between 40 and 59, tbree of 
them wi l l  have SC > 60 during the 2nd year of l ife 
3 R347H, initial SC > 60 
1 R l l7C ,  initial SC at 33 then 73 at 9 months 
1 R1070W, SC < 30 
1 $977F, initial SC at 51 then 60 at 3 months 
1 3849+10kb CoT ,  SC at 58 
These 17 atypical CF were followed regularly, except for 2 of them only seen by 
their GP and 1 lost of view. With 62 months of mean follow up (range 18 150), 4 
children have intermittent common respiratory signs, one of them had a P 
aeruginosa intermittent colonization at 3 years. We saw again at f ive one child only 
seen by his GP for recurrent respiratory signs. Al l  these CF are pancreatic sufficient, 
with normal respiratory functions. 
Condns ion In theory, to keep the diaguosis of CF among these children is perhaps 
debatable, but cl inical evolution is hard to predict. It's difficult o give genetic 
counsell ing to the family. A long term fol low up is necessary by a CF unit, once a 
year at leas% because CF s3,mptoms may appear later (and even early). Our 
experience and the others incite us to be careful. 
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CF NS, instituted since 1989 in Normandy, was recently generalized in France. A 
case control study was performed to assess the outcome at age 6y of a screened (S) 
compared to an unscreened (US) population, both centers having similar 
pr ceedures. 
From 33 S infants (Rouen) mad 49 US infants (Toulouse), genotypic mad 
demographic data, respiratory events, PA and SA colonization history, BMI  and the 
onset of pancreatic enzyme (PB) supply were collected. PFTs mad scored chest CT 
scans, using a Bhal la modified score (Robinson TE, J Pediatr, 2CO1) were 
performed. 
As expected, the diagnosis was made arl ier ha the S group compared to the US 
group and so was PB supply. The age of first SA colonization was signiBcantly 
lower in the S group than in the US group: 1.49 + 0.23 y and 3.01 + 0.26 y; p~).03. 
The proportion of children having carried PA at least once mad the age of the first 
PA colonization were similar in both groups: 94% and 2.78 + 0.4 y in S, and 92% 
and 3.29 + 0.3 y in US; p>0.1. No difference was observed between the infants that 
had carried PA at least once compared to those who never had PA. The 
br onchopulmonary disease at age 6y was similar. These parameters were not related 
to PA or SA colonization. 
Only an earl ier detection of SA was found in this comparative study. The high 
prevalence of first PA, but low chronic colonization in both centers suggests that PA 
detection depended on the pr ceedure more than on CF NS. This study confirms that 
NS improves nutritional management, but might not hRluence the mid term 
respiratory outcome. 
